查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1946065

全球感染控制产品市场：预测（至2034年）－按产品、最终使用者和地区分類的分析

Infection Control Products Market Forecasts to 2034 - Global Analysis By Product (Disinfectants, Sterilization Products, Personal Protective Equipment (PPE), Antiseptics and Infection Control Accessories), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的研究，预计到 2026 年，全球感染控制产品市场规模将达到 587.8 亿美元，在预测期内以 6.3% 的复合年增长率增长，到 2034 年将达到 958.3 亿美元。

感染控制产品是指用于预防、减少和控制医疗机构和社区中传染性病原体传播的专用仪器、化学物质和设备。这包括消毒剂、灭菌器、个人防护设备(PPE)、抗菌剂、洗手液分配器和废弃物处理系统。这些产品透过维持无菌环境、最大限度地减少交叉感染以及确保生物材料的安全处理，来保护患者、医护人员和公众。感染控制产品广泛应用于医院、诊所、实验室和居家照护，对于提高安全性、减少医疗相关感染以及支持公共卫生措施至关重要。

人们对医疗相关感染（HAI）的认识不断提高

感染控制产品市场正受到人们对医疗相关感染（HAI）日益增长的认识的推动，HAI对病人和医护人员构成严重风险。对交叉感染和医疗相关感染的担忧日益加剧，促使医院、诊所和实验室采用先进的消毒剂、个人防护设备（PPE）和灭菌产品。政府措施、宣传宣传活动和更严格的监管要求进一步强化了感染预防的需求。这种对卫生和安全的高度重视正在加速全球对综合感染控制解决方案的需求。

产品成本高

高昂的产品成本是感染控制产品市场的主要阻碍因素。先进的个人防护装备、消毒设备和自动化卫生系统通常涉及大量的製造、技术和合规相关高成本，这可能会阻碍小规模医疗机构、新兴市场和预算紧张的机构采用这些产品。因此，儘管需求不断增长，一些医疗机构仍然依赖传统的低成本产品。如何在成本效益、品质和法规遵循之间取得平衡，仍然是製造商和最终用户面临的关键挑战。

技术进步

技术创新为市场带来了巨大的成长机会。诸如紫外线C波段消毒设备、自动洗手液分发器、先进的灭菌设备和智慧个人防护装备等创新技术，能够提升安全性和合规性。这些解决方案优化了工作流程，减少了人为错误，并改善了医院、诊所和实验室的感染控制。数位化监控和物联网设备进一步加速了创新产品的普及应用。该领域持续的研发和创新，为製造商提供了拓展产品系列、应对不断变化的医疗保健挑战的机会。

供应链挑战

供应链挑战对市场构成威胁。原材料采购中断、生产延误和分销瓶颈都会影响产品供应，尤其是在新兴市场。对全球供应商提供关键化学品、聚合物和医用级材料会增加物流问题的风险。这些挑战可能导致消毒剂、个人防护设备(PPE) 和灭菌设备的交付延误，进而影响医疗机构维持感染控制标准的能力。健全的供应链管理对于降低这些风险并确保稳定的产品供应至关重要。

新冠疫情的影响：

新冠疫情对市场产生了深远的影响。全球对个人防护工具（PPE）、消毒剂、杀菌剂和灭菌设备的需求激增，凸显了医疗机构和社区感染防治的重要性。医疗机构加强了卫生通讯协定，各国政府也实施了严格的安全措施。儘管供应链一度中断，但随着新型消毒剂、自动分配器和紫外线C波段（UV-C）灭菌设备的研发，创新步伐加快。疫情后人们对安全和卫生的意识不断提高，预计将支撑市场的长期成长。

在预测期内，消毒剂细分市场预计将占据最大的市场份额。

在预测期内，消毒剂预计将占据最大的市场份额。这主要归功于其在医院、诊所和居家医疗中预防感染的关键作用。酒精类消毒剂、碘类消毒剂和氯己定广泛应用于手部卫生、术前准备和创伤护理。人们对医疗相关感染（HAI）的认识不断提高、监管标准的完善以及日常卫生习惯的养成，都推动了消毒剂市场的持续成长。由于消毒剂在预防感染方面提供了一种经济高效且易于获取的解决方案，因此它已成为医疗保健安全的基础，并已成为市场上的主要产品类型之一。

在预测期内，医院产业预计将呈现最高的复合年增长率。

在预测期内，由于患者数量庞大、感染控制法规严格以及对消毒剂、个人防护工具(PPE) 和无菌产品的持续需求，医院领域预计将呈现最高的成长率。医院正在投资先进技术，例如自动分配器、紫外线 C 消毒和智慧 PPE 系统，以提高安全性和效率。人们对医疗相关感染 (HAI) 的认识不断提高、监管合规要求日益严格以及对患者照护品质的日益重视，进一步推动了这些技术的应用，使医院领域成为全球增长最快的领域。

市占率最大的地区：

在预测期内，北美预计将保持最大的市场份额，这得益于其完善的医疗基础设施、严格的监管标准以及较高的感染控制通讯协定采纳率。该地区还拥有许多优势，例如先进的医院网路、强大的研发能力以及对创新产品的早期应用，例如自动分发器、紫外线消毒设备和先进的个人防护装备。政府为降低医院感染率所做的努力、广泛的社会意识提升以及高额的医疗保健支出，都进一步巩固了北美在全球感染控制产品市场的主导地位。

预计复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于医疗基础设施的快速扩张、感染预防意识的提高以及政府主导倡议的不断增加。医院网路的扩张、诊断检查室数量的增长以及对个人防护装备和无菌产品需求的上升正在推动市场成长。随着中国、印度、日本和东南亚等国家对感染控制技术的投资不断增加，以及创新产品的取得途径改善和应用加速，亚太地区正成为全球成长最快的区域市场。

免费客製化服务：

订阅本报告的用户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他公司（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣量身定制的主要国家/地区的市场估算、预测和复合年增长率（註：基于可行性检查）
  • 竞争性标竿分析
    • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章执行摘要

  • 市场概览及主要亮点
  • 成长要素、挑战与机会
  • 竞争格局概述
  • 战略考虑和建议

第二章：分析框架

  • 分析的目标和范围
  • 相关人员分析
  • 分析的前提条件与限制
  • 分析方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 科技与创新趋势
  • 新兴市场和高成长市场
  • 监管和政策环境
  • 感染疾病的影响及恢復前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商议价能力
    • 买方的议价能力
    • 替代产品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章 全球感染控制产品市场：依产品类别划分

  • 消毒剂
    • 表面消毒剂
    • 干洗手剂
    • 器械消毒剂
  • 无菌产品
    • 高压釜
    • 环氧乙烷
    • 过氧化氢消毒剂
  • 个人防护设备（PPE）
    • 口罩和呼吸防护设备
    • 手套
    • 罩衣和围裙
    • 面罩和护目镜
  • 消毒剂
    • 酒精类消毒剂
    • 碘基消毒剂
    • 氯己定
  • 感染控制用品
    • 消毒洗手液分配器
    • 废弃物处理系统
    • UV-C 消毒装置

第六章 全球感染控制产品市场：依最终用户划分

  • 医院
  • 诊所和医疗设施
  • 诊断检查室
  • 居家医疗
  • 其他最终用户

第七章 全球感染控制产品市场：依地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 南美洲其他地区
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第八章 战略市场资讯

  • 产业加值网络与供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第九章 产业趋势与策略倡议

  • 企业合併（M&A）
  • 伙伴关係、联盟和合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十章：公司简介

  • 3M Company
  • STERIS plc
  • Getinge AB
  • Ecolab Inc.
  • Cantel Medical Corporation
  • Becton, Dickinson and Company (BD)
  • Cardinal Health, Inc.
  • Kimberly Clark Corporation
  • Ansell Limited
  • Medline Industries, Inc.
  • Paul Hartmann AG
  • Reckitt Benckiser Group plc
  • Sotera Health LLC
  • Metrex Research, LLC
  • Diversey Holdings, Ltd.
Product Code: SMRC33839

According to Stratistics MRC, the Global Infection Control Products Market is accounted for $58.78 billion in 2026 and is expected to reach $95.83 billion by 2034 growing at a CAGR of 6.3% during the forecast period. Infection control products are specialized tools, chemicals, and equipment designed to prevent, reduce, and manage the spread of infectious agents in healthcare and community settings. They include disinfectants, sterilization devices, personal protective equipment (PPE), antiseptics, and hygiene accessories such as hand dispensers and waste disposal systems. These products protect patients, healthcare workers, and the public by maintaining sterile environments, minimizing cross contamination, and ensuring safe handling of biological materials. Widely used in hospitals, clinics, laboratories, and home care, infection control products are essential for enhancing safety, reducing healthcare-associated infections, and supporting public health initiatives.

Market Dynamics:

Driver:

Rising Awareness of Healthcare Associated Infections (HAIs)

The infection control products market is driven by increasing awareness of healthcare associated infections (HAIs), which pose serious risks to patients and healthcare workers. Rising concerns about cross-contamination and hospital-acquired infections are prompting hospitals, clinics, and laboratories to adopt advanced disinfectants, PPE, and sterilization products. Government initiatives, education campaigns, and stricter regulatory requirements further reinforce the need for infection prevention. This heightened focus on hygiene and safety is accelerating demand for comprehensive infection control solutions globally.

Restraint:

High Product Costs

High product costs are a key restraint for the infection control products market. Advanced PPE, sterilization equipment, and automated hygiene systems often involve significant manufacturing, technology, and compliance expenses. These elevated costs can limit adoption in small healthcare facilities, emerging markets, and budget-constrained institutions. As a result, while demand grows, some providers continue to rely on conventional, lower cost products. Balancing cost effectiveness with quality and regulatory compliance remains a critical challenge for manufacturers and end users alike.

Opportunity:

Technological Advancements

Technological advancements present significant growth opportunities in the market. Innovations such as UV-C decontamination devices, automated hand dispensers, advanced sterilizers, and smart PPE enhance safety and compliance. These solutions improve workflow, reduce human error, and optimize infection prevention outcomes in hospitals, clinics, and laboratories. Adoption of innovative products is further accelerated by digital monitoring and IoT-enabled devices. Continuous R&D and innovation in this space provide manufacturers the opportunity to expand product portfolios and address evolving healthcare challenges.

Threat:

Supply Chain Challenges

Supply chain challenges pose a threat to the market. Disruptions in raw material procurement, manufacturing delays, and distribution bottlenecks can affect product availability, particularly in emerging markets. Dependence on global suppliers for key chemicals, polymers, and medical-grade materials increases vulnerability to logistical issues. Such challenges may delay the delivery of disinfectants, PPE, and sterilization equipment, impacting healthcare facilities' ability to maintain infection control standards. Robust supply chain management is essential to mitigate these risks and ensure consistent product supply.

Covid-19 Impact:

The COVID-19 pandemic had a profound impact on the market. Demand for PPE, disinfectants, antiseptics, and sterilization equipment surged globally, highlighting the importance of infection prevention in healthcare and community settings. Healthcare facilities expanded hygiene protocols, while governments implemented strict safety measures. Supply chains faced temporary disruptions, but innovation accelerated with the development of novel disinfectants, automated dispensers, and UV-C sterilization devices. Post-pandemic, heightened awareness and continued focus on safety and hygiene are expected to sustain long-term market growth.

The antiseptics segment is expected to be the largest during the forecast period

The antiseptics segment is expected to account for the largest market share during the forecast period, due to its critical role in preventing infections in hospitals, clinics, and home care. Alcohol-based solutions, iodophors, and chlorhexidine are widely used for hand hygiene, preoperative preparation, and wound care. Growing awareness of HAIs, regulatory standards, and routine hygiene practices drive continuous demand. Antiseptics provide a cost-effective, accessible solution to infection prevention, making this segment a cornerstone of healthcare safety and the dominant product category in the market.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to high patient volumes, strict infection control regulations, and continuous need for disinfectants, PPE, and sterilization products. Hospitals are investing in advanced technologies such as automated dispensers, UV-C decontamination, and smart PPE systems to enhance safety and efficiency. Rising awareness of HAIs, regulatory compliance requirements, and increased focus on patient care quality further drives adoption, positioning hospitals as the fastest growing segment globally.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to well established healthcare infrastructure, stringent regulatory standards, and high adoption of infection control protocols. The region benefits from advanced hospital networks, strong R&D capabilities, and early adoption of innovative products such as automated dispensers, UV-C devices, and advanced PPE. Government initiatives to reduce HAIs, combined with widespread public awareness and high healthcare spending, reinforce North America's dominance in the global infection control products market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid healthcare infrastructure expansion, increasing awareness of infection prevention, and rising government initiatives. Growing hospital networks, expanding diagnostic laboratories, and rising demand for PPE and sterilization products drive market growth. Countries like China, India, Japan, and Southeast Asia are witnessing increasing investment in infection control technologies, enhancing access to innovative products and accelerating adoption, making Asia Pacific the fastest growing regional market globally.

Key players in the market

Some of the key players in Infection Control Products Market include 3M Company, STERIS plc, Getinge AB, Ecolab Inc., Cantel Medical Corporation, Becton, Dickinson and Company (BD), Cardinal Health, Inc., Kimberly-Clark Corporation, Ansell Limited, Medline Industries, Inc., Paul Hartmann AG, Reckitt Benckiser Group plc, Sotera Health LLC, Metrex Research, LLC and Diversey Holdings, Ltd.

Key Developments:

In September 2025, 3M has joined the JOINT3 consortium, a global collaboration focused on developing next generation semiconductor packaging technologies such as panel level organic interposers, which improve production efficiency and performance for advanced chips.

In March 2025, 3M has joined Europe's H2UB open innovation hydrogen platform as a corporate partner, contributing its materials and market expertise to support start-ups, mentor innovators, and accelerate hydrogen technology development across the value chain. This collaboration strengthens the ecosystem, fosters innovation in the hydrogen economy, and helps bring new solutions to industrial implementation more rapidly.

Products Covered:

  • Disinfectants
  • Sterilization Products
  • Personal Protective Equipment (PPE)
  • Antiseptics
  • Infection Control Accessories

End Users Covered:

  • Hospitals
  • Clinics & Healthcare Facilities
  • Diagnostic Laboratories
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Infection Control Products Market, By Product

  • 5.1 Disinfectants
    • 5.1.1 Surface Disinfectants
    • 5.1.2 Hand Disinfectants
    • 5.1.3 Instrument Disinfectants
  • 5.2 Sterilization Products
    • 5.2.1 Autoclaves
    • 5.2.2 Ethylene Oxide
    • 5.2.3 Hydrogen Peroxide Sterilizers
  • 5.3 Personal Protective Equipment (PPE)
    • 5.3.1 Masks & Respirators
    • 5.3.2 Gloves
    • 5.3.3 Gowns & Aprons
    • 5.3.4 Face Shields & Goggles
  • 5.4 Antiseptics
    • 5.4.1 Alcohol based Antiseptics
    • 5.4.2 Iodophors
    • 5.4.3 Chlorhexidine
  • 5.5 Infection Control Accessories
    • 5.5.1 Hand Hygiene Dispensers
    • 5.5.2 Waste Disposal Systems
    • 5.5.3 UV C Decontamination Devices

6 Global Infection Control Products Market, By End User

  • 6.1 Hospitals
  • 6.2 Clinics & Healthcare Facilities
  • 6.3 Diagnostic Laboratories
  • 6.4 Home Care Settings
  • 6.5 Other End Users

7 Global Infection Control Products Market, By Geography

  • 7.1 North America
    • 7.1.1 United States
    • 7.1.2 Canada
    • 7.1.3 Mexico
  • 7.2 Europe
    • 7.2.1 United Kingdom
    • 7.2.2 Germany
    • 7.2.3 France
    • 7.2.4 Italy
    • 7.2.5 Spain
    • 7.2.6 Netherlands
    • 7.2.7 Belgium
    • 7.2.8 Sweden
    • 7.2.9 Switzerland
    • 7.2.10 Poland
    • 7.2.11 Rest of Europe
  • 7.3 Asia Pacific
    • 7.3.1 China
    • 7.3.2 Japan
    • 7.3.3 India
    • 7.3.4 South Korea
    • 7.3.5 Australia
    • 7.3.6 Indonesia
    • 7.3.7 Thailand
    • 7.3.8 Malaysia
    • 7.3.9 Singapore
    • 7.3.10 Vietnam
    • 7.3.11 Rest of Asia Pacific
  • 7.4 South America
    • 7.4.1 Brazil
    • 7.4.2 Argentina
    • 7.4.3 Colombia
    • 7.4.4 Chile
    • 7.4.5 Peru
    • 7.4.6 Rest of South America
  • 7.5 Rest of the World (RoW)
    • 7.5.1 Middle East
      • 7.5.1.1 Saudi Arabia
      • 7.5.1.2 United Arab Emirates
      • 7.5.1.3 Qatar
      • 7.5.1.4 Israel
      • 7.5.1.5 Rest of Middle East
    • 7.5.2 Africa
      • 7.5.2.1 South Africa
      • 7.5.2.2 Egypt
      • 7.5.2.3 Morocco
      • 7.5.2.4 Rest of Africa

8 Strategic Market Intelligence

  • 8.1 Industry Value Network and Supply Chain Assessment
  • 8.2 White-Space and Opportunity Mapping
  • 8.3 Product Evolution and Market Life Cycle Analysis
  • 8.4 Channel, Distributor, and Go-to-Market Assessment

9 Industry Developments and Strategic Initiatives

  • 9.1 Mergers and Acquisitions
  • 9.2 Partnerships, Alliances, and Joint Ventures
  • 9.3 New Product Launches and Certifications
  • 9.4 Capacity Expansion and Investments
  • 9.5 Other Strategic Initiatives

10 Company Profiles

  • 10.1 3M Company
  • 10.2 STERIS plc
  • 10.3 Getinge AB
  • 10.4 Ecolab Inc.
  • 10.5 Cantel Medical Corporation
  • 10.6 Becton, Dickinson and Company (BD)
  • 10.7 Cardinal Health, Inc.
  • 10.8 Kimberly Clark Corporation
  • 10.9 Ansell Limited
  • 10.10 Medline Industries, Inc.
  • 10.11 Paul Hartmann AG
  • 10.12 Reckitt Benckiser Group plc
  • 10.13 Sotera Health LLC
  • 10.14 Metrex Research, LLC
  • 10.15 Diversey Holdings, Ltd.

List of Tables

  • Table 1 Global Infection Control Products Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Infection Control Products Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Infection Control Products Market Outlook, By Disinfectants (2023-2034) ($MN)
  • Table 4 Global Infection Control Products Market Outlook, By Surface Disinfectants (2023-2034) ($MN)
  • Table 5 Global Infection Control Products Market Outlook, By Hand Disinfectants (2023-2034) ($MN)
  • Table 6 Global Infection Control Products Market Outlook, By Instrument Disinfectants (2023-2034) ($MN)
  • Table 7 Global Infection Control Products Market Outlook, By Sterilization Products (2023-2034) ($MN)
  • Table 8 Global Infection Control Products Market Outlook, By Autoclaves (2023-2034) ($MN)
  • Table 9 Global Infection Control Products Market Outlook, By Ethylene Oxide (2023-2034) ($MN)
  • Table 10 Global Infection Control Products Market Outlook, By Hydrogen Peroxide Sterilizers (2023-2034) ($MN)
  • Table 11 Global Infection Control Products Market Outlook, By Personal Protective Equipment (PPE) (2023-2034) ($MN)
  • Table 12 Global Infection Control Products Market Outlook, By Masks & Respirators (2023-2034) ($MN)
  • Table 13 Global Infection Control Products Market Outlook, By Gloves (2023-2034) ($MN)
  • Table 14 Global Infection Control Products Market Outlook, By Gowns & Aprons (2023-2034) ($MN)
  • Table 15 Global Infection Control Products Market Outlook, By Face Shields & Goggles (2023-2034) ($MN)
  • Table 16 Global Infection Control Products Market Outlook, By Antiseptics (2023-2034) ($MN)
  • Table 17 Global Infection Control Products Market Outlook, By Alcohol based Antiseptics (2023-2034) ($MN)
  • Table 18 Global Infection Control Products Market Outlook, By Iodophors (2023-2034) ($MN)
  • Table 19 Global Infection Control Products Market Outlook, By Chlorhexidine (2023-2034) ($MN)
  • Table 20 Global Infection Control Products Market Outlook, By Infection Control Accessories (2023-2034) ($MN)
  • Table 21 Global Infection Control Products Market Outlook, By Hand Hygiene Dispensers (2023-2034) ($MN)
  • Table 22 Global Infection Control Products Market Outlook, By Waste Disposal Systems (2023-2034) ($MN)
  • Table 23 Global Infection Control Products Market Outlook, By UV C Decontamination Devices (2023-2034) ($MN)
  • Table 24 Global Infection Control Products Market Outlook, By End User (2023-2034) ($MN)
  • Table 25 Global Infection Control Products Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 26 Global Infection Control Products Market Outlook, By Clinics & Healthcare Facilities (2023-2034) ($MN)
  • Table 27 Global Infection Control Products Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • Table 28 Global Infection Control Products Market Outlook, By Home Care Settings (2023-2034) ($MN)
  • Table 29 Global Infection Control Products Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.